Therefore, based on the prediction of the gepia2 database and the mRNA level of clinical patients' tumor tissues, we explored the role of FBXL16 in affecting cell proliferation and promoting the MPA (mycophenolic acid) resistance of endometrial cancer cells in vitro and in vivo. This evidence concerns the gene FBXL16 and neoplasm.